2013
DOI: 10.1016/j.contraception.2012.10.023
|View full text |Cite
|
Sign up to set email alerts
|

In situ breakage of Implanon® — two cases of a rare occurrence

Abstract: Background: In situ breakage of Implanon® is a rare occurrence with unknown clinical significance. Authors report two different cases of broken Implanon® of women attended at our Family Planning Clinic. Discussion: In situ implants may spontaneously and asymptomatically break, although some uncertainty relies on whether that situation has a real impact on the contraceptive effectiveness or on bleeding patterns. Even more, it can be argued if, as a result of an occurrence of that nature, the implant shall or sh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 4 publications
0
7
0
Order By: Relevance
“…It is unknown if an implant remains as effective after a fracture in vivo. In humans, the fracture of an implant in situ is rare, and little is known about the clinical consequences [26][27][28][29][30]. There is no official recommendation by the manufacturers on when to remove a fractured ENG implant.…”
Section: Discussionmentioning
confidence: 99%
“…It is unknown if an implant remains as effective after a fracture in vivo. In humans, the fracture of an implant in situ is rare, and little is known about the clinical consequences [26][27][28][29][30]. There is no official recommendation by the manufacturers on when to remove a fractured ENG implant.…”
Section: Discussionmentioning
confidence: 99%
“…17,18,22 If the IUD is located in the intraperitoneal cavity, treatment for presumed pelvic inflammatory disease (PID) should be instituted. 27 These case reports do suggest that, in some cases, broken devices may lead to increased vaginal bleeding/spotting with improvement of symptoms after replacement of the device. The risk for expulsion is highest in the first 3 months after insertion and occurs in approximately 1 in 20 women, more commonly in nulliparous and younger women.…”
Section: Device Placement and Migrationmentioning
confidence: 94%
“…In this report, 1 of the rods was noted to have separated into 2 pieces without trauma, while the other rod broke into 2 pieces after the arm was grabbed forcefully. 3 This article cites unpublished data from Merck indicating that the release rate of etonogestrel may be altered by rod breakage. 3 This source stated that during development the implants were purposely damaged to determine the effect on hormone release.…”
Section: Introductionmentioning
confidence: 99%
“…3 This article cites unpublished data from Merck indicating that the release rate of etonogestrel may be altered by rod breakage. 3 This source stated that during development the implants were purposely damaged to determine the effect on hormone release. In response to the article from Elliman, Rekers 4 , a Merck employee, references the same unpublished Merck data of in vitro release of etonogestrel in damaged implants.…”
Section: Introductionmentioning
confidence: 99%